Aarhus University logo

    • About
      • About the Nordic EMBL Partnership
      • Mission statement
      • EMBL non-tenure model
      • Contact
    • News
    • Collaborations
      • NORPOD - Postdoctoral Researcher Programme
      • Nordic EMBL Partnership Meetings
      • Nordic EMBL Partnership Science and Art
    • Research
    • Technologies
    • Training
    • Careers
    Read more about the three new projects

    DANDRITE

    The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.

    FIMM

    The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.

    MIMS

    The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.

    NCMBM

    The Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) is the Norwegian node of the Nordic EMBL Partnership. NCMBM conducts molecular medicine & biotech research and works to translate these findings into clinical practice. 

    News from the Partnership


    MIMS Symposium 2022: a platform for showcasing collaboration in basic, translational and clinical research

    a lecture hall with people looking at the screen
    17 November 2022 - Events

    MIMS welcomed its Executive Board and research community to the MIMS Symposium to share significant advances in research and its growing Baltic…

    Family history is not sufficient for assessing inherited disease risk

    09 November 2022

    A new study from the University of Helsinki demonstrates the added value of genetic information in measuring inherited disease risk, alongside the…

    How cryo-EM revealed the secrets of enterovirus replication

    Two researchers at a desk looking at computer screens
    09 November 2022

    How a virus hijacks a host cell to make new virus particles is a key question in the prevention and treatment of virus-caused diseases.

    Sekulić group uses HDX-MS to characterize antibody with potential for breast cancer treatment and diagnostics developed by Kyte group at Oslo University Hospital

    09 November 2022 - Research news

    The study used HDX-MS to map the epitope and paratope of the new high-affinity tumor-specific antibody developed against a variant of HER2. Antibodies…

    Page 24 of 71.

    • Previous
    • 1
    • …
    • 23
    • 24
    • 25
    • …
    • 71
    • Next

    Upcoming Partnership Events


    No events found.

    Follow us!

    Follow us for the latest updates and insights! Join our community and stay connected with us on the following platforms

    LinkedIn
    Bluesky
    X

     

    The Nordic EMBL Partnership for Molecular Medicine combines the complementary research expertise of the Nordic countries with a common aim to address some of the biggest challenges in biomedicine today.

     

     

    About 

    News 

    Collaborations

    Research

    Technologies

    Training

    Careers

     

     

    Revised 24.06.2025

    © — Cookies at au.dk
    Privacy Policy
    Accessibility Statement

    15450 / i43